Clinical Trial Update: A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines [Phase 2]

View source ↗

Summary

A Phase 2 two-arm study evaluating Acthar Injection Gel for chronic migraines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Acthar Injection Gel (repository corticotropin injection)

Snippet

Sponsor: Dent Neuroscience Research Center | Conditions: Chronic Migraine | Phase 2 | Status: COMPLETED